Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions.
Market Cap | 7.125 Billion | Shares Outstanding | 102.575 Million | Avg 30-day Volume | 771.426 Thousand |
P/E Ratio | 26.5646 | Dividend Yield | 0.0 | EPS | 0.76 |
Price to Revenue | 1.3635 | Debt to Equity | 0.8568 | EBITDA | 685.588 Million |
Price to Book Value | 2.2193 | Operating Margin | 8.029300000000001 | Enterprise Value | 10.134 Billion |
Current Ratio | 1.102 | EPS Growth | 0.188 | Quick Ratio | 1.003 |
1 Yr BETA | 1.1167 | 52-week High/Low | 104.18 / 62.28 | Profit Margin | 5.1327 |
Operating Cash Flow Growth | -16.6318 | Altman Z-Score | 1.7738 | Free Cash Flow to Firm | 132.018 Million |
Earnings Report | 2022-11-02 |
Please sign in first
none
23.7 Thousand total shares from 10 transactions
none
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-07-29 17:01:13 -0400 | 2022-07-28 | S | 1,002 | $78.00 | d | 47,552 | direct | yes | -17.6144 | -13.4951 | 0.0 | 1 | -17.6144 | 2 | ||
BROOKS MICHAEL LEE - Officer CHIEF OPERATING OFFICER by spouse |
2022-07-29 17:01:13 -0400 | 2022-07-28 | S | 500 | $78.00 | d | 9,342 | indirect | yes | -17.6144 | -13.4951 | 0.0 | 1 | -17.6144 | 2 | |
2022-07-22 17:02:12 -0400 | 2022-07-21 | S | 1,002 | $76.00 | d | 48,554 | direct | yes | -0.2114 | 4.5581 | 4.5581 | 5 | -0.2114 | 2 | ||
BROOKS MICHAEL LEE - Officer CHIEF OPERATING OFFICER by spouse |
2022-07-22 17:02:12 -0400 | 2022-07-21 | S | 500 | $76.00 | d | 9,842 | indirect | yes | -0.2114 | 4.5581 | 4.5581 | 5 | -0.2114 | 2 | |
2022-07-21 17:04:06 -0400 | 2022-07-20 | S | 2,215 | $75.00 | d | 25,292 | direct | yes | -0.1715 | 4.3788 | 4.3788 | 6 | -0.3825 | 3 | ||
2022-07-20 17:04:55 -0400 | 2022-07-19 | S | 1,002 | $74.00 | d | 49,556 | direct | yes | -1.0054 | 3.3164 | 3.3164 | 6 | -1.384 | 4 | ||
BROOKS MICHAEL LEE - Officer CHIEF OPERATING OFFICER by spouse |
2022-07-20 17:04:55 -0400 | 2022-07-19 | S | 500 | $74.00 | d | 10,342 | indirect | yes | -1.0054 | 3.3164 | 3.3164 | 6 | -1.384 | 4 | |
2022-07-20 17:03:20 -0400 | 2022-07-18 | S | 7,500 | $72.81 | d | 54,736 | direct | yes | -1.0054 | 3.3164 | 3.3164 | 6 | -1.384 | 4 | ||
2022-07-20 17:04:06 -0400 | 2022-07-18 | S | 8,333 | $72.81 | d | 71,266 | direct | yes | -1.0054 | 3.3164 | 3.3164 | 6 | -1.384 | 4 | ||
KRALOWETZ DONNA HILDEBRAND - Officer EVP, CHIEF ACCOUNTING OFFICER |
2022-07-18 17:03:48 -0400 | 2022-07-15 | A | 2,426 | a | 9,231 | direct | 1.4736 | 2.109 | 3.542 | 3 | 0.0 | 1 | |||
KRALOWETZ DONNA HILDEBRAND - Officer EVP, CHIEF ACCOUNTING OFFICER |
2022-07-11 17:05:44 -0400 | 2022-07-08 | S | 1,149 | $73.16 | d | 6,805 | direct | yes | 1.0496 | 4.922 | 4.922 | 6 | 0.0 | 1 | |
KRALOWETZ DONNA HILDEBRAND - Officer SVP, CHIEF ACCOUNTING OFFICER |
2022-06-21 17:23:36 -0400 | 2022-06-17 | F | 247 | $64.31 | d | 7,954 | direct | 6.8633 | 10.2874 | 4.6316 | 20.9722 | 27 | -0.3363 | 29 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
SYNEOS HEALTH INC SYNH | 2022-08-12 22:15:03 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 21:45:04 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 21:15:04 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 20:45:04 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 20:15:05 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 19:45:03 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 19:15:05 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 18:45:03 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 18:15:04 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 17:45:04 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 17:15:05 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 16:45:04 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 16:15:04 UTC | 1.9119 | 0.4081 | 3200000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 15:45:04 UTC | 1.9119 | 0.4081 | 3100000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 15:15:05 UTC | 1.9119 | 0.4081 | 3100000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 14:45:04 UTC | 1.9119 | 0.4081 | 3100000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 14:15:05 UTC | 1.9119 | 0.4081 | 3100000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 13:45:04 UTC | 1.9119 | 0.4081 | 3100000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 13:15:04 UTC | 1.9119 | 0.4081 | 3100000 |
SYNEOS HEALTH INC SYNH | 2022-08-12 12:45:04 UTC | 1.9119 | 0.4081 | 3100000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
FundVantage Trust- Gotham Defensive Long Fund | SYNH | -56.0 shares, $-2207.52 | 2020-03-31 | N-PORT |
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund | SYNH | -122.0 shares, $-6491.62 | 2019-09-30 | N-PORT |
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund | SYNH | -38403.0 shares, $-2806875.27 | 2022-04-30 | N-PORT |